The rare disease burden: a multidimensional challenge.

IF 1.4 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY
Acta biochimica Polonica Pub Date : 2025-07-14 eCollection Date: 2025-01-01 DOI:10.3389/abp.2025.14777
Zuzanna Cyske, Edyta Radzanowska-Alenowicz, Estera Rintz, Lidia Gaffke, Karolina Pierzynowska
{"title":"The rare disease burden: a multidimensional challenge.","authors":"Zuzanna Cyske, Edyta Radzanowska-Alenowicz, Estera Rintz, Lidia Gaffke, Karolina Pierzynowska","doi":"10.3389/abp.2025.14777","DOIUrl":null,"url":null,"abstract":"<p><p>Although there no single, widely accepted definition of a \"rare disease,\" this group of disorders includes conditions that affect only a small fraction of the population. A large number of rare diseases is caused by defined molecular defects, predominantly the occurrence of pathogenic variant(s) of genes. Thus, they are classified as \"genetic diseases,\" among which there are many neurodegenerative disorders. Despite a low incidence of each such disease, majority of them are severe and no effective treatment is available. This creates a battery of problems for millions of people suffering from these disease as well as to their relatives and caregivers. However, the set of problems is larger; therefore, in this narrative review we summarize and discuss various kinds of problems caused by rare disease, including severe symptoms of patients, everyday problems of patients and caregivers, loneliness and social exclusion, diagnostic difficulties, unavailability of effective therapies and economic difficulties in introducing orphan drugs, and a complexity of studies on rare diseases due to low availability of biological material and complicated pathomechanisms. The global picture of the complex problems caused by rare diseases is presented.</p>","PeriodicalId":6984,"journal":{"name":"Acta biochimica Polonica","volume":"72 ","pages":"14777"},"PeriodicalIF":1.4000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12301258/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta biochimica Polonica","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.3389/abp.2025.14777","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Although there no single, widely accepted definition of a "rare disease," this group of disorders includes conditions that affect only a small fraction of the population. A large number of rare diseases is caused by defined molecular defects, predominantly the occurrence of pathogenic variant(s) of genes. Thus, they are classified as "genetic diseases," among which there are many neurodegenerative disorders. Despite a low incidence of each such disease, majority of them are severe and no effective treatment is available. This creates a battery of problems for millions of people suffering from these disease as well as to their relatives and caregivers. However, the set of problems is larger; therefore, in this narrative review we summarize and discuss various kinds of problems caused by rare disease, including severe symptoms of patients, everyday problems of patients and caregivers, loneliness and social exclusion, diagnostic difficulties, unavailability of effective therapies and economic difficulties in introducing orphan drugs, and a complexity of studies on rare diseases due to low availability of biological material and complicated pathomechanisms. The global picture of the complex problems caused by rare diseases is presented.

罕见病负担:一个多方面的挑战。
虽然没有一个被广泛接受的“罕见病”的定义,但这组疾病包括只影响一小部分人口的疾病。大量罕见病是由确定的分子缺陷引起的,主要是基因致病性变异的发生。因此,它们被归类为“遗传疾病”,其中有许多神经退行性疾病。尽管这些疾病的发病率都很低,但大多数都很严重,没有有效的治疗方法。这给数百万患有这些疾病的人以及他们的亲属和照顾者带来了一系列问题。然而,问题的集合更大;因此,在本文中,我们总结和讨论罕见病引起的各种问题,包括患者的严重症状,患者和护理人员的日常问题,孤独感和社会排斥,诊断困难,有效治疗方法的缺乏和引入孤儿药的经济困难,以及罕见病研究的复杂性由于生物材料的低可获得性和复杂的病理机制。介绍了罕见病引起的复杂问题的全球概况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta biochimica Polonica
Acta biochimica Polonica 生物-生化与分子生物学
CiteScore
2.40
自引率
0.00%
发文量
99
审稿时长
4-8 weeks
期刊介绍: Acta Biochimica Polonica is a journal covering enzymology and metabolism, membranes and bioenergetics, gene structure and expression, protein, nucleic acid and carbohydrate structure and metabolism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信